488 related articles for article (PubMed ID: 28433750)
41. Design and optimization of thermosensitive nanoemulsion hydrogel for sustained-release of praziquantel.
Cong Z; Shi Y; Peng X; Wei B; Wang Y; Li J; Li J; Li J
Drug Dev Ind Pharm; 2017 Apr; 43(4):558-573. PubMed ID: 27935330
[TBL] [Abstract][Full Text] [Related]
42. Low-surfactant microemulsions for enhanced topical delivery of poorly soluble drugs.
Shalviri A; Sharma AC; Patel D; Sayani A
J Pharm Pharm Sci; 2011; 14(3):315-24. PubMed ID: 21824447
[TBL] [Abstract][Full Text] [Related]
43. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
44. Gellan gum fluid gels for topical administration of diclofenac.
Mahdi MH; Conway BR; Mills T; Smith AM
Int J Pharm; 2016 Dec; 515(1-2):535-542. PubMed ID: 27789369
[TBL] [Abstract][Full Text] [Related]
45. Formulation and evaluation of ophthalmic preparations of acetazolamide.
Kaur IP; Singh M; Kanwar M
Int J Pharm; 2000 Apr; 199(2):119-27. PubMed ID: 10802405
[TBL] [Abstract][Full Text] [Related]
46. [Ion-sensitive nanoemulsion-in situ gel system for ophthalmic delivery of flurbiprofen axetil].
Shen JQ; Gan Y; Gan L; Zhu CL; Zhu JB
Yao Xue Xue Bao; 2010 Jan; 45(1):120-5. PubMed ID: 21351461
[TBL] [Abstract][Full Text] [Related]
47. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery.
Gupta H; Velpandian T; Jain S
J Drug Target; 2010 Aug; 18(7):499-505. PubMed ID: 20055752
[TBL] [Abstract][Full Text] [Related]
48. In situ-gelling gellan formulations as vehicles for oral drug delivery.
Miyazaki S; Aoyama H; Kawasaki N; Kubo W; Attwood D
J Control Release; 1999 Aug; 60(2-3):287-95. PubMed ID: 10425334
[TBL] [Abstract][Full Text] [Related]
49. A Novel Gel-Forming Solution Based on PEG-DSPE/Solutol HS 15 Mixed Micelles and Gellan Gum for Ophthalmic Delivery of Curcumin.
Sai N; Dong X; Huang P; You L; Yang C; Liu Y; Wang W; Wu H; Yu Y; Du Y; Leng X; Yin X; Qu C; Ni J
Molecules; 2019 Dec; 25(1):. PubMed ID: 31878332
[TBL] [Abstract][Full Text] [Related]
50. Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation.
Hosny KM; Hassan AH
Int J Pharm; 2014 Nov; 475(1-2):191-7. PubMed ID: 25178831
[TBL] [Abstract][Full Text] [Related]
51. Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops.
Sultana Y; Aqil M; Ali A
Drug Deliv; 2006; 13(3):215-9. PubMed ID: 16556574
[TBL] [Abstract][Full Text] [Related]
52. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride.
Balasubramaniam J; Pandit JK
Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139
[TBL] [Abstract][Full Text] [Related]
53.
Elmowafy E; Cespi M; Bonacucina G; Soliman ME
Pharm Dev Technol; 2019 Dec; 24(10):1258-1271. PubMed ID: 31437077
[TBL] [Abstract][Full Text] [Related]
54. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
[TBL] [Abstract][Full Text] [Related]
55. In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin.
Balasubramaniam J; Kant S; Pandit JK
Acta Pharm; 2003 Dec; 53(4):251-61. PubMed ID: 14769232
[TBL] [Abstract][Full Text] [Related]
56. Gastroretentive Cosolvent-Based In Situ Gel as a Promising Approach for Simultaneous Extended Delivery and Enhanced Bioavailability of Mitiglinide Calcium.
Mahmoud DB; Shukr MH; ElMeshad AN
J Pharm Sci; 2019 Feb; 108(2):897-906. PubMed ID: 30267785
[TBL] [Abstract][Full Text] [Related]
57. Tailoring the mucoadhesive and sustained release characteristics of mesalamine loaded formulations for local treatment of distal forms of ulcerative colitis.
Ali HS; Hanafy AF; El Achy SN
Eur J Pharm Sci; 2016 Oct; 93():233-43. PubMed ID: 27503459
[TBL] [Abstract][Full Text] [Related]
58. Xanthan and gum acacia modified olive oil based nanoemulsion as a controlled delivery vehicle for topical formulations.
Kobra K; Wong SY; Mazumder MAJ; Li X; Arafat MT
Int J Biol Macromol; 2023 Dec; 253(Pt 4):126868. PubMed ID: 37729997
[TBL] [Abstract][Full Text] [Related]
59. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
[TBL] [Abstract][Full Text] [Related]
60. Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole.
Khare P; Chogale MM; Kakade P; Patravale VB
Drug Deliv Transl Res; 2022 Dec; 12(12):2920-2935. PubMed ID: 35538191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
